Throckmorton DC, Gottlieb S, Woodcock J. The
FDA and the next wave of drug abuse - proactive
pharmacovigilance. N Engl J Med 2018; 379(3):
205-7.
2. Coyne CJ, Hall AR. Four decades and counting: The
continued failure of the war on drugs. Policy
Analysis 2017; 811. [Online]. [cited 2017 Apr 12];
Available from: URL:
https://www.cato.org/publications/policyanalysis/four-decades-counting-continued-failurewar-drugs
3. Cohen PT. Symbolic dimensions of the anti-opium
campaign in Laos. Aust J Anthropol 2013; 24(2):
177-92.
4. Des Jarlais DC. Harm reduction in the USA: the
research perspective and an archive to David
Purchase. Harm Reduct J 2017; 14(1): 51.
5. Daosodsai P, Bellis MA, Hughes K, Hughes S,
Daosodsai S, Syed Q. Thai war on drugs: Measuring
changes in methamphetamine and other substance use
by school students through matched cross sectional
surveys. Addict Behav 2007; 32(8): 1733-9.
6. Go JR. Of choices, changes, and challenges: The
Philippines in 2016. Philipp Polit Sci J 2017; 38(1):
48-73.
7. Hawk M, Coulter RWS, Egan JE, Fisk S, Reuel FM,
Tula M, et al. Harm reduction principles for
healthcare settings. Harm Reduct J 2017; 14(1): 70.
8. Ball AL. HIV, injecting drug use and harm
reduction: A public health response. Addiction 2007;
102(5): 684-90.
9. Cook C, Bridge J, Stimson GV. The diffusion of
harm reduction in Europe and beyond. In: Rhodes T,
Hedrich D, editors. Monographs 10: Harm reduction:
Evidence, impacts and challenges. 2010. Lisbon,
Portugal: European Monitoring Centre for Drugs and
Drug Addiction; P. 37-58.
10. Tibke P. Drug dependence treatment in China: A
policy analysis [Online]. [cited 2017 Feb]; Available
from: URL: http://fileserver.idpc.net/library/IDPCbriefing-paper_China-drug-treatment.pdf
11. World Health Organization. The world health report
2000: Health systems: Improving performance.
Geneva, Switzerland: WHO; 2000.
12. Stone K, Shirley-Beavan S. Global state of harm
reduction 2018 [Online]. [cited 2018]; Available
from: URL: https://www.hri.global/global-stateharm-reduction-2018
13. Sander G. The Death Penalty for Drug Offences:
Global Overview 2017 [Online]. [cited 2018 Mar];
Available from: URL:
https://www.hri.global/files/2018/11/13/HRI-DeathPenalty-Report-2018-v2.pdf
14. Sapsford R, Jupp V. Data collection and analysis.
Thousand Oaks, CA: SAGE Publications; 2006.
15. CIA World Factbooks. Countries Compared by
Government > Government type [Online]. [cited
2019]; Available from: URL:
https://www.nationmaster.com/countryinfo/stats/Government/Government-type
16. Legatum Institute Foundation. The Legatum
Prosperity Index™ 2018: Creating the Pathways
from Poverty to Prosperity [Online]. [cited 2018];
Available from: URL:
Cross-country Comparison of Drug Abuse Policies Mehrolhasani et al.
90 Addict Health, Spring 2019; Vol 11 , No 2
http://ahj.kmu.ac.ir, 04 April
https://www.prosperity.com/rankings
17. The World Bank Group. Countries and Economies
[Online]. [cited 2019]; Available from: URL:
https://data.worldbank.org/country
18. World Health Organization. Countries [Online].
[cited 2019]; Available from: URL:
https://www.who.int/countries/en/
19. United Nations Development Programme. Human
Development Reports [Online]. [cited 2018];
Available from: URL: http://hdr.undp.org/en/2018-
update/download
20. United Nations Office on Drugs and Crime. World
Drug Report 2018 [Online]. [cited 2018]; Available
from: URL: https://www.unodc.org/wdr2018/
21. Ritchie H. Substance Use - Our World in Data
[Online]. [cited 2018]; Available from: URL:
https://ourworldindata.org/substance-use
22. Seghatoleslam T, Habil H, Hatim A, Rashid R,
Ardakan A, Esmaeili MF. Achieving a spiritual
therapy standard for drug dependency in Malaysia,
from an Islamic Perspective: brief review article.
Iran J Public Health 2015; 44(1): 22-7.
23. Rahimipoor I, Habibzadeh MJ, Mohaghegh Damad
M, Farajiha M, Omidi J. A comparative study of Iran
legislative policy with Portugal and Canada.
Comparative Law Researches 2016; 20(3): 84-110.
[In Persian].
24. Schatz E. The Dutch Treatment and Social Support
System for Drug Users: Recent Developments and
the Example of Amsterdam [Online]. [cited 2011
Aug 15]; Available from: URL:
https://ssrn.com/abstract=1908913
25. Li J, Ha TH, Zhang C, Liu H. The Chinese
government's response to drug use and HIV/AIDS:
A review of policies and programs. Harm Reduct J
2010; 7: 4.
26. European Monitoring Centre for Drugs and Drug
Addiction. Germany, Country Drug Report 2017
[Online]. [cited 2017 Jun]; Available from: URL:
http://www.emcdda.europa.eu/publications/countrydrug-reports/2017/germany_en
27. Kanato M, Leyatikul P, Choomwattana C. ASEAN
drug Monitoring Report 2016 [Online]. [cited 2017
Nov 15]; Available from: URL: https://asean.org/wpcontent/uploads/2016/10/Doc6-ADM-Report-2016-
as-of-15-November-2017-FINAL.pdf
28. Lu L, Fang Y, Wang X. Drug abuse in China: Past,
present and future. Cell Mol Neurobiol 2008; 28(4):
479-90.
29. Mojtahedzadeh V, Razani N, Malekinejad M,
Vazirian M, Shoaee S, Saberi Zafarghandi MB, et al.
Injection drug use in rural Iran: Integrating HIV
prevention into Iran's rural primary health care
system. AIDS Behav 2008; 12(4 Suppl): S7-S12.
30. Yang M, Zhou L, Hao W, Xiao SY. Drug policy in
China: Progress and challenges. Lancet 2014;
383(9916): 509.
31. Vicknasingam B, Mazlan M. Malaysian drug
treatment policy: An evolution from total abstinence
to harm reduction. Malaysian Anti-Drugs Journa
2008; 107-21
32. Alam-Mehrjerdi Z, Abdollahi M, Higgs P, Dolan K.
Drug use treatment and harm reduction programs in
Iran: A unique model of health in the most populated
Persian Gulf country. Asian J Psychiatr 2015; 16:
78-83.
33. European Monitoring Centre for Drugs and Drug
Addiction. Netherlands: Country Drug Report 2018
[Online]. [cited 2018]; Available from: URL:
http://www.emcdda.europa.eu/countries/drugreports/2018/netherlands_en
34. Krishnan A, Brown SE, Ghani MA, Khan F,
Kamarulzaman A, Altice FL. Pretreatment drug use
characteristics and experiences among patients in a
voluntary substance abuse treatment center in
Malaysia: A mixed-methods approach. Subst Abus
2016; 37(4): 542-9.
35. Meng J, Burris S. The role of the Chinese police in
methadone maintenance therapy: A literature review.
Int J Drug Policy 2013; 24(6): e25-e34.
36. Lunze K, Lermet O, Andreeva V, Hariga F.
Compulsory treatment of drug use in Southeast
Asian countries. Int J Drug Policy 2018; 59: 10-5.
37. Nikpour G. Drugs and drug policy in the Islamic
Republic of Iran. Middle East Briefs 2019; 119: 2-7.
38. Lievens D, Vander LF, Christiaens J. Public
spending for illegal drug and alcohol treatment in
hospitals: An EU cross-country comparison. Subst
Abuse Treat Prev Policy 2014; 9: 26.
39. Michels II, Stover H. Harm reduction--from a
conceptual framework to practical experience: the
example of Germany. Subst Use Misuse 2012; 47(8-
9): 910-22.
40. Kamarulzaman A, Mcbrayer J. Compulsory
detention as drug treatment and the impact on HIV
outcomes. Proceedings of UNODC Scientific Event
Science Addressing Drugs and Health: State of the
Art; 2014 Mar 11; Vienna, Austria.
41. Ebrahimi S. Evaluation of the Coping Policies of the
Islamic Republic of Iran in Combating Drugs and
Reducing Addiction. Tehran, Iran: University of
Tehran; 2007. [In Persian].
42. Norden L, van Veen M, Lidman C, Todorov I,
Guarita B, Kretzschmar M, et al. Hepatitis C among
injecting drug users is two times higher in Stockholm,
Sweden than in Rotterdam, the Netherlands. Subst
Use Misuse 2013; 48(14): 1469-74.
43. International Drug Policy Consortium. IDPC Drug
Policy Guide. 3rd ed. London, UK: IDPC; 2016
44. Iran Drug Control Headquarters. Legislation for drug
Cross-country Comparison of Drug Abuse Policies Mehrolhasani et al.
Addict Health, Spring 2019; Vol 11 , No 2 91
http://ahj.kmu.ac.ir, 04 April
treatment and harm reduction centers [Online]. [cited
2010]; Available from: URL:
http://qavanin.ir/Law/TreeText/202008
45. World Health Organization. World Health
Organization’s Ranking of the World’s Health
Systems. Geneva, Switzerland: WHO; 2000
46. Euchner EM, Heichel S, Nebel K, Raschzok A.
From ‘morality’policy to ‘normal’policy: Framing of
drug consumption and gambling in Germany and the
Netherlands and their regulatory consequences. J Eur
Public Policy 2013; 20(3): 372-89.
47. Lake I. The 10th Asian Informal Drug Policy
Dialogue [Online]. [cited 2019 May 2]; Available
from URL: https://www.tni.org/en/publication/the-
10th-asian-informal-drug-policy-dialogue
48. United Nations. JOINT Statement Compulsory Drug
Detention and Rehabilitation Centre [Online]. [cited
2012 Mar]; Available from: URL:
https://www.who.int/hhr/JC2310_joint_statement_20
120306final_en.pdf?ua=1